Acinetobacter Infections – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Acinetobacter is a complex genus that commonly causes nosocomial infections, predominantly aspiration pneumonia and catheter-associated bacteremia, and also causes soft tissue and urinary tract infections. Transmission of Acinetobacter and subsequent disease is facilitated by the organism's environmental tenacity, resistance to desiccation, and evasion of host immunity. Acinetobacter spp. is found in wet environments, including moist soil/mud, wetlands, ponds, water treatment plants, fish farms, wastewater, and seawater. These environmental strains often harbor antibiotic resistance mechanisms, including carbapenemases and extended-spectrum β-lactamases (ESBLs). They may thus serve as important ecological reservoirs for resistance elements that transform into clinically relevant strains. Some medically relevant species, such as A. calcoaceticus, A. lwoffii, A. nosocomial, and A. pittii, have been found on vegetables, meat, dairy products, and human skin. Acinetobacter spp. is often transmitted to patients via persistence on environmental surfaces and transient colonization of the hands of healthcare workers. However, nosocomial spread by aerosolized bacteria from infected or colonized patients has been reported.
·
Acinetobacter infections have spread rapidly
through hospitals across the globe. The infection ranges from 2 to 7% of all
hospital-related infections.
Thelansis’s “Acinetobacter Infections
Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report
– 2022 To 2032" covers disease overview, epidemiology, drug utilization,
prescription share analysis, competitive landscape, clinical practice,
regulatory landscape, patient share, market uptake, market forecast, and key
market insights under the potential Acinetobacter Infections treatment
modalities options for eight major markets (USA, Germany, France, Italy, Spain,
UK, Japan, and China).
KOLs insights
of Acinetobacter Infections across 8 MM market from the centre of Excellence/
Public/ Private hospitals participated in the study. Insights around current
treatment landscape, epidemiology, clinical characteristics, future treatment
paradigm, and Unmet needs.
Acinetobacter Infections Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment